Siemens

Siemens Presents New Product Lines for Angiography

Siemens HealthcareSiemens Healthcare has developed a revolutionary new X-ray tube and detector technology for its Artis Q and Artis Q.zen angiography systems to improve minimally invasive therapy of diseases such as coronary artery disease, stroke and cancer. In both the Artis Q and Artis Q.zen series, the new X-ray tube can help to identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this innovative Xray source with a new detector technology that supports interventional imaging in ultra-low dose ranges. This protects patients, doctors and medical staff, especially during longer interventions. With these new developments, presented for the first time at the 98th Congress of the Radiological Society of North America (RSNA), Siemens Healthcare has once again demonstrated its innovative strength and market competitiveness as part of its Agenda 2013 global Sector initiative.

Two hardware components are crucial for angiographic image quality: the X-ray tube and the detector. The X-rays emitted by the tube pass through the patient and hit the detector, which converts them to image signals.

The second generation of Siemens' flat emitter technology is key to the advances made in the Xray tube for the Artis Q and Artis Q.zen product lines. Instead of the coiled filaments used in conventional X-ray tubes, flat emitter technology is used exclusively in the new tube to emit electrons. Flat emitters enable smaller quadratic focal spots that lead to improved visibility of small vessels by up to 70 percent. Both physicians and patients benefit from a high level of detail in imaging-supported interventional therapy. Neurologists can more precisely measure the blood circulation in specific areas of the brain, for example; while stenoses in the heart's smallest blood vessels can be spotted in coronary angiography.

Examinations using ultra-low dose radiation
The Artis Q.zen series combines the X-ray tube with a detector technology that allows detection at ultra-low radiation levels. Artis Q.zen imaging can use doses as low as half the usual levels normally applied in angiography. This improvement is the result of several innovations, including a fundamental change in detector technology. Until now, almost all detectors have been based on amorphous silicon. The new crystalline silicon structure of the Artis Q.zen detector is more homogenous, allowing for more effective amplification of the signal, greatly reducing the electronic noise even at ultra-low doses.

The Artis Q.zen was developed to support better imaging quality at ultra-low-dose ranges, reducing the radiation exposure of patients, physicians, and medical staff. This is especially important in dose-sensitive application fields such as pediatric cardiology and radiology, or electrophysiology, which is being used on more and more patients as rates of cardiac arrhythmia increase in an aging population.

Innovative applications for interventional imaging
In addition to the hardware innovations are several software applications that improve interventional imaging. In coronary artery disease treatment, the applications allow precise correlation of angiography images with ultrasound images taken by a probe inside the coronary arteries. Stents are imaged in real-time during therapy, with motion stabilization created by simultaneous correction for the heartbeat.

Other new 3D applications can image the smallest structures inside the head. Their high spatial resolution is crucial for imaging intracranial stents or other miniscule structures, such as the cochlea in the inner ear. Moving organs such as the lungs can be imaged in 3D in less than 3 seconds, reducing the number of motion artifacts and the amount of contrast agent required. Through visualization and measurement of blood volumes in the liver or other organs, Siemens' functional 3D imaging provides a basis for planning therapies such as chemo-embolization of hepatic tumors.

Launched in November 2011 by the Siemens Healthcare Sector, "Agenda 2013" is a two-year global initiative to further strengthen the Healthcare Sector's innovative power and competitiveness. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros.

Most Popular Now

Weighing the Pros and Cons of Menta…

"There's an app for that." The phrase is so ubiquitous it's a meme, and trademarked by Apple Inc. In fact there are more than 165,000 mobile applications available for he...

Read more

The Entrepreneurial Village for Eur…

8 - 10 June 2016, Amsterdam, The Netherlands. The Entrepreneurial Village at eHealth Week 2016 will give you the opportunity to meet and connect with the highest profile...

Read more

Data Analytics for Unstructured Cli…

Clinical case notes are vital to delivering high-quality, coordinated patient care and optimising resources across the health economy. Yet case notes are unstructured and...

Read more

Open Call SC1-PM-07-2017: Promoting…

Proposals should develop population-oriented primary prevention interventions to promote mental well-being of young people and assess them for their effectiveness. The ...

Read more

A Future without Desktops - Address…

Opinion Article by Matthew Kybert, Systems Development & Integration Manager at The Hillingdon Hospitals NHS Foundation Trust. When clinicians in Hillingdon became the f...

Read more

IMS MAXIMS Successfully Awarded a P…

IMS MAXIMS has been awarded a place on the Crown Commercial Service (CCS) new Digital Outcomes and Specialists (DOS) Framework. The DOS Framework is one of three compleme...

Read more

Online Therapy Effective at Treatin…

Doctors from the University of Pittsburgh showed that providing an online computerized cognitive behavioral therapy (CCBT) program both alone and in combination with Inte...

Read more

Evar Guidance Engine Software Makes…

At the Charing Cross Congress in London, Siemens Healthcare presents the Evar Guidance Engine software application package to support minimally invasive treatment of aort...

Read more

Doctors 2.0 & YOU 2016

26 - 27 May, Paris, France. Doctors 2.0 & YOU, the International Digital Health Congress that offers to every health professionals the opportunity to understand how to u...

Read more

A Personalized Virtual Heart Predic…

When electrical waves in the heart run amok in a condition called arrhythmia, sudden death can occur. To save the life of a patient at risk, doctors currently implant a s...

Read more

New Tool Measures Lung Function ove…

Most people in the developing world who have asthma, cystic fibrosis or other chronic lung diseases have no way to measure how well their lungs are functioning outside of...

Read more

Grants4Apps Accelerator 2016: You I…

The Grants4Apps (G4A) Accelerator developed by Bayer invites health IT and technology startups to apply for the program's 2016 edition. This year, Bayer looks primarily i...

Read more

Digest Newsletter

Subscribe to our weekly Newsletter and stay updated on the latest eHealth News. Subscribe now, it's free!
© eHealthNews.eu 2006 - 2016